These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35746770)

  • 1. Expanding Mouse-Adapted Yamagata-like Influenza B Viruses in Eggs Enhances In Vivo Lethality in BALB/c Mice.
    Pekarek MJ; Petro-Turnquist EM; Rubrum A; Webby RJ; Weaver EA
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Single Amino Acid in the Polymerase Acidic Protein Determines the Pathogenicity of Influenza B Viruses.
    Bae JY; Lee I; Kim JI; Park S; Yoo K; Park M; Kim G; Park MS; Lee JY; Kang C; Kim K; Park MS
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
    Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
    Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of high-yield influenza B virus vaccine viruses.
    Ping J; Lopes TJ; Neumann G; Kawaoka Y
    Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8296-E8305. PubMed ID: 27930325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Infection Using Mouse-Adapted Influenza B Virus in a Mouse Model.
    Prokopyeva E; Kurskaya O; Sobolev I; Solomatina M; Murashkina T; Suvorova A; Alekseev A; Danilenko D; Komissarov A; Fadeev A; Ramsay E; Shestopalov A; Dygai A; Sharshov K
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32326238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, Immunogenicity, and Protective Efficacy of an H5N1 Chimeric Cold-Adapted Attenuated Virus Vaccine in a Mouse Model.
    Sun W; Wang Z; Sun Y; Li D; Zhu M; Zhao M; Wang Y; Xu J; Kong Y; Li Y; Feng N; Wang T; Zhao Y; Yang S; Gao Y; Xia X
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single N342D substitution in Influenza B Virus NA protein determines viral pathogenicity in mice.
    Zhou L; Feng Z; Liu J; Chen Y; Yang L; Liu S; Li X; Gao R; Zhu W; Wang D; Shu Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1853-1863. PubMed ID: 32746754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment.
    Marathe BM; Mostafa HH; Vogel P; Pascua PNQ; Jones JC; Russell CJ; Webby RJ; Govorkova EA
    Antiviral Res; 2017 Dec; 148():20-31. PubMed ID: 29100887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus.
    Nakamura K; Harada Y; Takahashi H; Trusheim H; Bernhard R; Hamamoto I; Hirata-Saito A; Ogane T; Mizuta K; Konomi N; Konomi Y; Asanuma H; Odagiri T; Tashiro M; Yamamoto N
    Vaccine; 2019 Oct; 37(43):6526-6534. PubMed ID: 31500967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors.
    Fage C; Abed Y; Checkmahomed L; Venable MC; Boivin G
    Viruses; 2018 Dec; 11(1):. PubMed ID: 30583488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice.
    Moser MJ; Hatta Y; Gabaglia C; Sanchez A; Dias P; Sarawar S; Kawaoka Y; Hatta M; Neumann G; Bilsel P
    Vaccine; 2019 Jul; 37(32):4533-4542. PubMed ID: 31280945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a high yield vaccine backbone for influenza B virus in embryonated chicken eggs.
    Aslam S; Rajendran M; Kriti D; Kurland A; Johnson J; van Bakel H; Krammer F; García-Sastre A; Ayllon J
    NPJ Vaccines; 2023 Feb; 8(1):12. PubMed ID: 36765053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective.
    Madsen A; Dai YN; McMahon M; Schmitz AJ; Turner JS; Tan J; Lei T; Alsoussi WB; Strohmeier S; Amor M; Mohammed BM; Mudd PA; Simon V; Cox RJ; Fremont DH; Krammer F; Ellebedy AH
    Immunity; 2020 Oct; 53(4):852-863.e7. PubMed ID: 32976769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple amino acid substitutions involved in the adaption of three avian-origin H7N9 influenza viruses in mice.
    Qin J; Peng O; Shen X; Gong L; Xue C; Cao Y
    Virol J; 2019 Jan; 16(1):3. PubMed ID: 30621708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized clade 2.3.2.1c H5N1 recombinant-vaccine strains against highly pathogenic avian influenza.
    Jang JW; Lee CY; Kim IH; Choi JG; Lee YJ; Yuk SS; Lee JH; Song CS; Kim JH; Kwon HJ
    J Vet Sci; 2017 Aug; 18(S1):299-306. PubMed ID: 28859269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cultured, live attenuated, X-31ca-based H5N1 pre-pandemic influenza vaccine.
    Lee YH; Jang YH; Seong BL
    Virology; 2017 Apr; 504():73-78. PubMed ID: 28157547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccines.
    Jang YH; Jung EJ; Byun YH; Lee KH; Lee EY; Lee YJ; Seong BL
    Vaccine; 2013 Jul; 31(33):3339-46. PubMed ID: 23742997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of a live attenuated influenza B virus vaccine candidate.
    Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
    Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs.
    Alymova IV; Kodihalli S; Govorkova EA; Fanget B; Gerdil C; Webster RG
    J Virol; 1998 May; 72(5):4472-7. PubMed ID: 9557744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B.
    Gong X; Yin H; Shi Y; He X; Yu Y; Guan S; Kuai Z; Haji NM; Haji NM; Kong W; Shan Y
    Emerg Microbes Infect; 2016 May; 5(5):e51. PubMed ID: 27222326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.